Literature DB >> 221475

A protein activator for the adenylate cyclase of Bordetella pertussis.

E L Hewlett, L H Underhill, G H Cook, C R Manclark, J Wolff.   

Abstract

The activity of Bordetella pertussis extracytoplasmic adenylate cyclase is 100-fold higher in organisms grown on blood agar than in those grown in synthetic medium. This increase in activity is due to in vivo activation of the enzyme by a factor present in erythrocytes. Activation also occurs in killed or disrupted organisms. The activator can be separated from heme proteins and has been purified approximately 100-fold from erythrocytes, yielding material of approximately 105,000 daltons. It is sensitive to trypsin and alpha-chymotrypsin and exhibits considerable heat stability. Activation of cyclase in intact B. pertussis organisms exhibits a lag of 3 to 4 min and is not reversed by washing. Response to the activator decreases with increasing purification of the adenylate cyclase and is absent in the pure enzyme. The activation does not appear to be proteolytic and does not appear to change access to the substrate, ATP. The activator has no effect on a number of eukaryotic cyclases. We conclude that this is a new type of activation and that the activator differs from all those previously described.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221475

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases.

Authors:  H R Masure; R L Shattuck; D R Storm
Journal:  Microbiol Rev       Date:  1987-03

2.  Calmodulin activates prokaryotic adenylate cyclase.

Authors:  J Wolff; G H Cook; A R Goldhammer; S A Berkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

3.  Adenylate cyclase activity of a 68,000-molecular-weight protein isolated from the outer membrane of Bordetella bronchiseptica.

Authors:  P Novotny; A P Chubb; K Cownley; J A Montaraz
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

4.  Novel inhibitors of anthrax edema factor.

Authors:  Deliang Chen; Milind Misra; Laurie Sower; Johnny W Peterson; Glen E Kellogg; Catherine H Schein
Journal:  Bioorg Med Chem       Date:  2008-06-28       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.